You are here

Article info

Article menu
Download PDFPDF
Correspondence
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic

Authors

  • Konstantinos Parperis Internal Medicine, Division of Rheumatology, University of Cyprus Medical School, Nicosia, Cyprus Medicine, Division of Rheumatology, University of Arizona College of Medicine, Phoenix, Arizona, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Konstantinos Parperis, Internal Medicine, Division of Rheumatology, University of Cyprus Medical School, Nicosia 1678, Cyprus; kparpe02{at}ucy.ac.cy
View Full Text

Citation

Parperis K
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic
Annals of the Rheumatic Diseases 2021;80:e8.

Publication history

  • Received April 9, 2020
  • Accepted April 13, 2020
  • First published April 22, 2020.
Online issue publication 
December 14, 2020

Article Versions

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage